EntreMed, Inc. announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma (MM) cell lines and in MM models in vivo.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced the introduction of a new GMP compliant radiochemical solution, Lu-177 nuclide.
In any battle, sizing up one's opponent is a critical first step. For researchers fighting a bacterial infection, that means assessing every nook and cranny of the malicious microorganism and identifying which ones to attack.
The number of young people infected with HIV in Africa is falling in 16 of the 25 countries hardest hit by the virus, according to a new report by a U.N. agency.
As the FDA began a two-day meeting to discuss Avandia's future, it became clear that the agency's own scientists are deeply divided. The FDA will ask a panel of outside advisers to untangle the mess of data that has stumped its own scientists for more than three years.
CoDa Therapeutics’ lead product candidate NEXAGON achieved positive results in tissue repair in a Phase 2 clinical study in patients with venous leg ulcers.
The Eppendorf Xplorer pipette offers better pipetting with simplicity, precision, and reproducibility. With the Xplorer you get precisely adjustable parameters, maximum reproducible results, and fatigue-free work.
Thermo Scientific has just launched miRIDIAN shMIMIC Lentiviral microRNAs, which incorporate innovative design strategies that allow consistent processing of the mature microRNA and enhanced specificity, making them ideal for a variety of microRNA research applications.
KAEL-GemVax, a leading oncology vaccine company, has announced, encouraging interim progress from the UK-based Phase III TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in pancreatic cancer.
New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.
SAIC-Frederick, Inc. and Fluidigm Corporation are collaborating to decode the entire genome of the Epstein-Barr virus (EBV) using technology that can speed up research on the genetic basis of cancer and other diseases.
Amid growing concerns about clinical trials for drugs that have been approved by the FDA but are later linked to serious health risks, an independent committee at the Institute of Medicine has developed a conceptual framework to guide the agency through the tough decision of ordering such controversial "post-market" drug-safety trials.
Drug and medical device maker Covidien said it has closed its $2.6 billion acquisition of endovascular surgery device maker ev3 Inc.
An exhaustive 700-page review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug.
President Barack Obama is announcing a new national strategy for combatting HIV and AIDS, aimed at stopping new infections and increasing access to care for people living with the virus.